Summary
The inputs into clinical trials are many and the possibilities for study are nearly infinite. The only way rational choices and priorities can be established is through the use of experimental models. Clinicians and experimentalists must develop a continuous dialogue so as to mutually develop their questions of importance for study.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Carter SK (1977) Chemotherapy of head and neck cancer. Semin Oncol 4:413–424
Carter SK (1977) Clinical trials in cancer chemotherapy. Cancer 40:544–557
Carter SK, Bakowski M, Hellmann K (1977) Chemotherapy of cancer. John Wiley & Sons, New York
Randolph UL, Vallejo A, Spiro R, Shan J., Strong, EW, Huvos AG, Wittes, GE (1978) Combination therapy of advanced head and neck cancer. Cancer 41:460–467
Wittes RE, Cvitkovic E, Shah J, Gerold FP, Strong EW (1977) Cis-dichlorodiammine dichloride in the treatment of epidermoid carcinoma of the head and neck. Cancer Treat Rep 61:359–366
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1980 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Carter, S.K. (1980). Clinical Chemotherapy: Its Correlation with Experimental Models. In: Mathé, G., Muggia, F.M. (eds) Cancer Chemo- and Immunopharmacology. Recent Results in Cancer Research, vol 74. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-81488-4_4
Download citation
DOI: https://doi.org/10.1007/978-3-642-81488-4_4
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-81490-7
Online ISBN: 978-3-642-81488-4
eBook Packages: Springer Book Archive